drugset

drugset / Trial / NCT01081704

A Study of the Pharmacokinetics of Ustekinumab in Chinese Male Subjects

NCT01081704 ↗

Phase 1 Completed 24 enrolled Centocor, Inc.

RandomizedParallel-groupOpen-labelTreatment

Summary

A study of the pharmacokinetics of ustekinumab in Chinese male subjects.

Timeline

Start: 2009-10
Primary completion: 2010-06
Completion: 2010-06

Publications

Zhu Y, Wang Q, Frederick B, Bouman-Thio E, Marini JC, Keen M, Petty KJ, Davis HM, Zhou H. Comparison of the pharmacokinetics of subcutaneous ustekinumab between Chinese and non-Chinese healthy male subjects across two Phase 1 studies. Clin Drug Investig. 2013 Apr;33(4):291-301. doi: 10.1007/s40261-013-0072-2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Ustekinumab	Monoclonal antibody	45 mg	Subcutaneous
Subject	Ustekinumab	Monoclonal antibody	90 mg	Subcutaneous

Indications

No indication recorded.